BLUE

bluebird bio, Inc. News Headlines

$165.89
*  
6.72
4.22%
Get BLUE Alerts
*Delayed - data as of Jul. 31, 2015  -  Find a broker to begin trading BLUE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By











An Assessment Of Celgene's Deal For Receptos
7/21/2015 12:46:00 PM - Seeking Alpha




Celgene: Is This Range Bound Stock Ready To Go Higher?
7/13/2015 7:04:00 PM - Seeking Alpha


GlaxoSmithKline's Gene Therapy Coming Of Age?
7/10/2015 7:27:00 AM - Seeking Alpha


Biotech At A Fraught Mid-Year: An Overview And Look Ahead
7/9/2015 11:48:00 AM - Seeking Alpha




Benitec And Bluebird Bio, Gene Therapy Coming Of Age?
7/6/2015 12:24:00 PM - Seeking Alpha








Today's Market: Big Biotech And Technology Deals
6/30/2015 8:44:00 AM - Seeking Alpha




Bluebird Feathers Nest While Going Is Good
6/25/2015 12:51:00 PM - Seeking Alpha